BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 28115501)

  • 1. Towards better antimicrobial susceptibility testing: impact of the Journal of Antimicrobial Chemotherapy.
    Wootton M; MacGowan AP; Howe RA
    J Antimicrob Chemother; 2017 Feb; 72(2):323-329. PubMed ID: 28115501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harmonization of antimicrobial susceptibility testing breakpoints in Europe: implications for reporting intermediate susceptibility.
    Brown D; Macgowan A
    J Antimicrob Chemother; 2010 Feb; 65(2):183-5. PubMed ID: 19996143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a rational antimicrobial testing policy in the laboratory.
    Banaji N; Oommen S
    Indian J Med Microbiol; 2011; 29(3):209-12. PubMed ID: 21860098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ability of laboratories to detect emerging antimicrobial resistance: proficiency testing and quality control results from the World Health Organization's external quality assurance system for antimicrobial susceptibility testing.
    Tenover FC; Mohammed MJ; Stelling J; O'Brien T; Williams R
    J Clin Microbiol; 2001 Jan; 39(1):241-50. PubMed ID: 11136778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories.
    Matuschek E; Brown DF; Kahlmeter G
    Clin Microbiol Infect; 2014 Apr; 20(4):O255-66. PubMed ID: 24131428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bringing Antimicrobial Susceptibility Testing for New Drugs into the Clinical Laboratory: Removing Obstacles in Our Fight against Multidrug-Resistant Pathogens.
    Kirby JE; Brennan-Krohn T; Smith KP
    J Clin Microbiol; 2019 Dec; 57(12):. PubMed ID: 31533983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial susceptibility testing in the clinical laboratory.
    Holland TL; Woods CW; Joyce M
    Infect Dis Clin North Am; 2009 Dec; 23(4):757-90, vii. PubMed ID: 19909884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial resistance: action by laboratories today for a cure tomorrow.
    Kanungo R
    Indian J Med Microbiol; 2011; 29(3):205-6. PubMed ID: 21860096
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antimicrobial susceptibility testing of bacteria isolated from animals: considerations concerning the predefinition of breakpoints from the clinical pharmacological viewpoint].
    Kietzmann M; Böttner A; Hafez HM; Kehrenberg C; Klarmann D; Krabisch P; Kühn T; Luhofer G; Richter A; Schwarz S; Traeder W; Waldmann KH; Wallmann J; Werckenthin C; ;
    Berl Munch Tierarztl Wochenschr; 2004; 117(3-4):81-7. PubMed ID: 15046455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New consensus guidelines from the Clinical and Laboratory Standards Institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria.
    Jorgensen JH; Hindler JF
    Clin Infect Dis; 2007 Jan; 44(2):280-6. PubMed ID: 17173232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility testing: a critical evaluation.
    Isenberg HD
    J Antimicrob Chemother; 1988 Jul; 22 Suppl A():73-86. PubMed ID: 3209539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear magnetic resonance applied to antimicrobial drug susceptibility.
    García-Álvarez L; Busto JH; Peregrina JM; Fernández Recio MA; Avenoza A; Oteo JA
    Future Microbiol; 2013 Apr; 8(4):537-47. PubMed ID: 23534364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of antimicrobial susceptibility testing practices of veterinary diagnostic laboratories in the United States.
    Brooks MB; Morley PS; Dargatz DA; Hyatt DR; Salman MD; Akey BL
    J Am Vet Med Assoc; 2003 Jan; 222(2):168-73. PubMed ID: 12555979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical microbiology as a basis of antimicrobial chemotherapy].
    Spencker FB
    Z Gesamte Inn Med; 1992 Sep; 47(9):394-7. PubMed ID: 1441666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BSAC standardized disc susceptibility testing method (version 10).
    Andrews JM; Howe RA;
    J Antimicrob Chemother; 2011 Dec; 66(12):2726-57. PubMed ID: 21921076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of interlaboratory variability on antimicrobial susceptibility determination.
    Annis DH; Craig BA
    Diagn Microbiol Infect Dis; 2005 Sep; 53(1):61-4. PubMed ID: 16182077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BSAC standardized disc susceptibility testing method (version 5).
    Andrews JM;
    J Antimicrob Chemother; 2006 Sep; 58(3):511-29. PubMed ID: 16840429
    [No Abstract]   [Full Text] [Related]  

  • 18. Survey, laboratory and statistical methods for the BSAC Resistance Surveillance Programmes.
    Reynolds R; Hope R; Williams L;
    J Antimicrob Chemother; 2008 Nov; 62 Suppl 2():ii15-28. PubMed ID: 18819976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance and susceptibility testing of anaerobic bacteria.
    Schuetz AN
    Clin Infect Dis; 2014 Sep; 59(5):698-705. PubMed ID: 24867792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of rapid in vitro susceptibility testing and bacterial identification.
    Doern GV; Vautour R; Gaudet M; Levy B
    J Clin Microbiol; 1994 Jul; 32(7):1757-62. PubMed ID: 7929770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.